biologics Archives - Express Pharma

COPD market to surpass $30.2 billion in 7MM in 2033, driven by biologics and precision medicine, forecasts GlobalData

OX40 inhibitors may transform atopic dermatitis landscape: GlobalData

Syngene concludes acquisition of Emergent BioSolutions’ biologics manufacturing facility

Targeted therapies and improved diagnostics remain needs unmet in T2-low asthma

Biologic therapies show progress in severe asthma treatment and remission potential

Jubilant Biosys signs partnership with Pierre Fabre SA

Biocon Biologics report explores pathways to increase biosimilar adoption in low- and middle-income countries

OneSource pharma launches new brand identity at CPHI, Milan

Enzene appoints new site lead for flagship US continuous biomanufacturing facility

Aragen setting up a $ 30mn bio-manufacturing site in Bengaluru